Correlation Between Oxford Nanopore and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Oxford Nanopore and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Zentalis Pharmaceuticals.
Diversification Opportunities for Oxford Nanopore and Zentalis Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Oxford and Zentalis is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oxford Nanopore and Zentalis Pharmaceuticals
Assuming the 90 days horizon Oxford Nanopore Technologies is expected to under-perform the Zentalis Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Oxford Nanopore Technologies is 1.64 times less risky than Zentalis Pharmaceuticals. The pink sheet trades about -0.15 of its potential returns per unit of risk. The Zentalis Pharmaceuticals Llc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 310.00 in Zentalis Pharmaceuticals Llc on August 25, 2024 and sell it today you would earn a total of 13.00 from holding Zentalis Pharmaceuticals Llc or generate 4.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oxford Nanopore Technologies vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Oxford Nanopore Tech |
| Zentalis Pharmaceuticals |
Oxford Nanopore and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oxford Nanopore and Zentalis Pharmaceuticals
The main advantage of trading using opposite Oxford Nanopore and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Oxford Nanopore vs. Lineage Cell Therapeutics | Oxford Nanopore vs. Cadrenal Therapeutics, Common | Oxford Nanopore vs. ImmuCell | Oxford Nanopore vs. Braxia Scientific Corp |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |